Inventor · disambiguated record
Ralph Diodone
Also filed as: DIODONE RALPH
11 granted patents·14 pending applications·140 citations·filing 2007–2024
89Inventor score
Top patents by PatentIndex Score
25 records- 0195US9663517B2Compositions and uses thereofPLEXXIKON INC·Filed 2016·Granted May 30, 2017·31 cites·5 claims
- 0295US8865735B2Solid forms of a pharmaceutically active substanceIBRAHIM PRABHA N·Filed 2012·Granted Oct 21, 2014·56 cites·30 claims
- 0392US9447089B2Compositions and uses thereofDESAI DIPEN·Filed 2010·Granted Sep 20, 2016·46 cites·29 claims
- 0484US11814354B2Solid formsRIVER 3 RENAL CORP·Filed 2022·Granted Nov 14, 2023·1 cites·17 claims
- 0577US11040977B2Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crytalline forms thereofHOFFMANN LA ROCHE·Filed 2019·Granted Jun 22, 2021·1 cites·2 claims
- 0677US10246460B2Synthesis of trans-8-chloro-5-methyl-1-[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[E]azulene and crytalline forms thereofHOFFMANN LA ROCHE·Filed 2016·Granted Apr 2, 2019·2 cites·6 claims
- 0777US10221125B2Solid formsORYZON GENOMICS SA·Filed 2016·Granted Mar 5, 2019·2 cites·34 claims
- 0872US12134599B2Solid formsRIVER 3 RENAL CORP·Filed 2023·Granted Nov 5, 2024·0 cites·20 claims
- 0970US12459947B2Synthesis of trans-8-chloro-5-methyl-1 -[4-(pyridin-2-yloxy)-cyclohexyl]-5,6-dihydro-4H-2,3,5,10B-tetraaza-benzo[e]azulene and crystalline forms thereofHOFFMANN LA ROCHE·Filed 2021·Granted Nov 4, 2025·0 cites·2 claims
- 1069US2025263378A1Solid formsRIVER 3 RENAL CORP·Filed 2024·Application pending·0 cites
- 1166US8039473B2Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneHOFFMANN LA ROCHE·Filed 2010·Granted Oct 18, 2011·1 cites·13 claims
- 1263US2009105480A1Process for the preparation of a dpp-iv inhibitorBROMBERGER ULRIKE·Filed 2008·Application pending·0 cites
- 1362US2014350257A1Process for the Preparation of a DPP-IV InhibitorHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1461US2019241557A1Compositions and uses thereofPLEXXIKON INC·Filed 2018·Application pending·0 cites
- 1560US2014046066A1Process for the preparation of dpp-iv inhibitorHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1658US2018111930A1Compositions and uses thereofPLEXXIKON INC·Filed 2017·Application pending·0 cites
- 1756US2012232273A1Process for the preparation of a dpp-iv inhibitorBROMBERGER ULRIKE·Filed 2012·Application pending·0 cites
- 1855US2008214561A1Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneBUBENDORF ANDRE·Filed 2007·Application pending·0 cites
- 1955US2013197225A1New Solid Forms of [4-(3-Fluoro-5-Trifluoromethyl-Pyridin-2-Yl)-Piperazin-1-Yl-[5-Methanesulfonyl-2-((S)-2,2,2-Trifluoro-1-Methyl-Ethoxy)-Phenyl]MethanoneHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2053US2015336951A1Process For The Preparation Of A DPP-IV InhibitorHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2150US2012309969A1Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneBUBENDORF ANDRE·Filed 2012·Application pending·0 cites
- 2249US2011112136A1Novel process for the manufacture of pharmaceutical preparationsDIODONE RALPH·Filed 2010·Application pending·0 cites
- 2348US2011295007A1Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((s)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanoneBUBENDORF ANDRE·Filed 2011·Application pending·0 cites
- 2437US10227298B2Solid forms of a pharmaceutically active compoundHOFFMANN LA ROCHE·Filed 2015·Granted Mar 12, 2019·0 cites·12 claims
- 2535US2011313196A1Novel processBACHMANN STEPHAN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ralph Diodone files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →